Head to head

GentleMax Pro Plus vs Motus AZ+ (2026)

The biggest practical difference is cost of entry: Motus AZ+'s new pricing is $120k–$160k, while GentleMax Pro Plus's is $110k–$140k. They are used for different treatments (Motus AZ+: dual-wavelength (in-motion); GentleMax Pro Plus: alexandrite + nd:yag), so the right pick depends on which treatments you're building demand for.

Category group: Hair removal (diode, alexandrite, Nd:YAG, IPL)

Device A

Device B

Price comparison

Price comparison: DEKA Motus AZ+ vs Candela GentleMax Pro Plus
Attribute	DEKA Motus AZ+	Candela GentleMax Pro Plus
New price range	$120k–$160k	$110k–$140k
Used asking range	$80k–$110k	Used GentleMax Pro $35k–$65k
Payback calculator	View ROI calculator	View ROI calculator
Next step

New price range

DEKA Motus AZ+: $120k–$160k
Candela GentleMax Pro Plus: $110k–$140k

Used asking range

DEKA Motus AZ+: $80k–$110k
Candela GentleMax Pro Plus: Used GentleMax Pro $35k–$65k

Payback calculator

DEKA Motus AZ+: View ROI calculator
Candela GentleMax Pro Plus: View ROI calculator

Next step

DEKA Motus AZ+

Candela GentleMax Pro Plus

Consumable economics

Consumable economics: DEKA Motus AZ+ vs Candela GentleMax Pro Plus
Attribute	DEKA Motus AZ+	Candela GentleMax Pro Plus
Consumable cost / lock-in	No per-treatment consumables — gel and eventual sapphire-tip wear; a few thousand a year in maintenance reserve.	The DCD cryogen canister — a few dollars per treatment, roughly ~$2k-6k/year at busy-clinic volume; distance gauges and windows are minor wear items. Trivial next to a CoolSculpting-style tax, but not zero — put it in the model.
Service cost	Not published	Not published

Consumable cost / lock-in

DEKA Motus AZ+: No per-treatment consumables — gel and eventual sapphire-tip wear; a few thousand a year in maintenance reserve.
Candela GentleMax Pro Plus: The DCD cryogen canister — a few dollars per treatment, roughly ~$2k-6k/year at busy-clinic volume; distance gauges and windows are minor wear items. Trivial next to a CoolSculpting-style tax, but not zero — put it in the model.

Service cost

DEKA Motus AZ+: Not published
Candela GentleMax Pro Plus: Not published

FDA clearance

FDA clearance: DEKA Motus AZ+ vs Candela GentleMax Pro Plus
Attribute	DEKA Motus AZ+	Candela GentleMax Pro Plus
FDA status & indication	FDA ClearedK211821, K162886, K181486 “Alexandrite 755nm laser source: Temporary hair reduction. Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6,9, and 12 months after the completion of a treatment regime, on all skin types (Fitzpatrick I – VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. Photocoagulation of benign dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias). Nd:YAG 1064nm laser source: Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. The lasers are indicated on all Skin Types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of benign pigmented and benign vascular lesions, such as but not limited to port wine stains, hemangioma, warts, teleangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos, (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratosis, nevi, cloasma, verrucae, skin tags, keratosis and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles.”	FDA ClearedK201111, K112715, K133283 “755nm: Temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick I-VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias). 1064nm: Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.)”

FDA status & indication

DEKA Motus AZ+: FDA ClearedK211821, K162886, K181486
“Alexandrite 755nm laser source: Temporary hair reduction. Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6,9, and 12 months after the completion of a treatment regime, on all skin types (Fitzpatrick I – VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. Photocoagulation of benign dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias). Nd:YAG 1064nm laser source: Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. The lasers are indicated on all Skin Types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of benign pigmented and benign vascular lesions, such as but not limited to port wine stains, hemangioma, warts, teleangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos, (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratosis, nevi, cloasma, verrucae, skin tags, keratosis and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles.”
Candela GentleMax Pro Plus: FDA ClearedK201111, K112715, K133283
“755nm: Temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick I-VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias). 1064nm: Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.)”

Which chains run each

Which chains run each: DEKA Motus AZ+ vs Candela GentleMax Pro Plus
Attribute	DEKA Motus AZ+	Candela GentleMax Pro Plus
Chain adoption	0 recorded pairings	3 recorded pairings
Chains using it	—	Ideal Image(Confirmed) SEV Laser(Reported) European Wax Center(Confirmed)
Approved reviews	0	0

Chain adoption

DEKA Motus AZ+: 0 recorded pairings
Candela GentleMax Pro Plus: 3 recorded pairings

Chains using it

DEKA Motus AZ+: —
Candela GentleMax Pro Plus: Ideal Image(Confirmed)
SEV Laser(Reported)
European Wax Center(Confirmed)

Approved reviews

DEKA Motus AZ+: 0
Candela GentleMax Pro Plus: 0

Specs and platform

Specs and platform: DEKA Motus AZ+ vs Candela GentleMax Pro Plus
Attribute	DEKA Motus AZ+	Candela GentleMax Pro Plus
Manufacturer	DEKA	Candela
Built by (OEM)	DEKA M.E.L.A. S.r.l.	Candela Corporation
Category	Dual-wavelength (in-motion)	Alexandrite + Nd:YAG
Technology	755/1064nm Moveo, higher power (Alexandrite)	Dual 755nm alexandrite + 1064nm Nd:YAG (Alexandrite)
Launch year	2022	2021
Status	Current	Current (GentleMax Pro discontinued, huge used market)
OEM platform	—	—

Manufacturer

DEKA Motus AZ+: DEKA
Candela GentleMax Pro Plus: Candela

Built by (OEM)

DEKA Motus AZ+: DEKA M.E.L.A. S.r.l.
Candela GentleMax Pro Plus: Candela Corporation

Alternatives

Other devices in the same subcategory.

DEKA Motus AY

Dual-wavelength (in-motion)

New: —

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Prices are researched estimates, not quotes. Not medical, legal or regulatory advice.